Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in <i>RAS</i> - and <i>RAF</i> -Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass
- DOI
- 10.1158/0008-5472.can-25-4907
- Published
- 2026-07-30
- Container
- Cancer Research
- Publisher
- American Association for Cancer Research (AACR)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1158/0008-5472.can-25-4907,
title = {Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in
<i>RAS</i>
- and
<i>RAF</i>
-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass},
author = {Sarah Kolitz and Anna Travesa and Amy Axel and Jason M. Funt and Matthew S. Nord and Amy Yamamura and Kevin D. Fowler and Praveen Nair and Benjamin Zeskind and Brett M. Hall and Peter King},
year = {2026},
journal = {Cancer Research},
doi = {10.1158/0008-5472.can-25-4907},
url = {https://doi.org/10.1158/0008-5472.can-25-4907}
}RIS
TY - JOUR
TI - Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in
<i>RAS</i>
- and
<i>RAF</i>
-Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass
AU - Sarah Kolitz
AU - Anna Travesa
AU - Amy Axel
AU - Jason M. Funt
AU - Matthew S. Nord
AU - Amy Yamamura
AU - Kevin D. Fowler
AU - Praveen Nair
AU - Benjamin Zeskind
AU - Brett M. Hall
AU - Peter King
PY - 2026
JO - Cancer Research
DO - 10.1158/0008-5472.can-25-4907
UR - https://doi.org/10.1158/0008-5472.can-25-4907
ER - APA
Kolitz, S., Travesa, A., Axel, A., Funt, J. M., Nord, M. S., Yamamura, A., Fowler, K. D., Nair, P., Zeskind, B., Hall, B. M., & King, P. (2026). Dual-MEK Inhibitor Atebimetinib Displays Broad Activity in <i>RAS</i> - and <i>RAF</i> -Mutant Tumors via Deep Cyclic Inhibition and Resisting RAF Bypass. Cancer Research. https://doi.org/10.1158/0008-5472.can-25-4907
Source records
- crossref · retrieved 2026-09-27T13:21:25.993Z